4/12
06:27 am
seer
Seer, Inc. (NASDAQ:SEER) is a favorite amongst institutional investors who own 51% [Yahoo! Finance]
Medium
Report
Seer, Inc. (NASDAQ:SEER) is a favorite amongst institutional investors who own 51% [Yahoo! Finance]
3/5
11:02 am
seer
Seer, Inc. (NASDAQ: SEER) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $7.00 price target on the stock.
Medium
Report
Seer, Inc. (NASDAQ: SEER) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $7.00 price target on the stock.
2/29
04:51 pm
seer
Seer Inc (SEER) Reports Mixed Financial Results for Q4 and Full Year 2023 [Yahoo! Finance]
Neutral
Report
Seer Inc (SEER) Reports Mixed Financial Results for Q4 and Full Year 2023 [Yahoo! Finance]
2/29
04:26 pm
seer
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook [Yahoo! Finance]
Neutral
Report
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook [Yahoo! Finance]
2/29
04:05 pm
seer
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
Neutral
Report
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
2/21
04:05 pm
seer
Seer to Participate in the TD Cowen 44th Annual Health Care Conference
Neutral
Report
Seer to Participate in the TD Cowen 44th Annual Health Care Conference
2/6
08:13 am
seer
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery [Yahoo! Finance]
Medium
Report
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery [Yahoo! Finance]
2/6
08:00 am
seer
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
Medium
Report
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
2/2
11:30 am
seer
Here's Why Seer, Inc. (SEER) Could be Great Choice for a Bottom Fisher [Yahoo! Finance]
Low
Report
Here's Why Seer, Inc. (SEER) Could be Great Choice for a Bottom Fisher [Yahoo! Finance]
2/1
04:05 pm
seer
Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
Low
Report
Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024